SEC Filings

Filing date	Form	Description	View
02/15/18	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-18-010059.pdf 0001104659-18-010059.rtf 0001104659-18-010059.xls
02/15/18	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-18-002190.pdf 0001179110-18-002190.rtf 0001179110-18-002190.xls
02/15/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002191.pdf 0001179110-18-002191.rtf 0001179110-18-002191.xls
02/14/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002125.pdf 0001179110-18-002125.rtf 0001179110-18-002125.xls
02/14/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002132.pdf 0001179110-18-002132.rtf 0001179110-18-002132.xls
02/14/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002128.pdf 0001179110-18-002128.rtf 0001179110-18-002128.xls
02/14/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002120.pdf 0001179110-18-002120.rtf 0001179110-18-002120.xls
02/14/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002131.pdf 0001179110-18-002131.rtf 0001179110-18-002131.xls
02/14/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002123.pdf 0001179110-18-002123.rtf 0001179110-18-002123.xls
02/14/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-002127.pdf 0001179110-18-002127.rtf 0001179110-18-002127.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.